{"id":55736,"date":"2023-04-12T15:03:04","date_gmt":"2023-04-12T13:03:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/"},"modified":"2023-04-12T15:03:04","modified_gmt":"2023-04-12T13:03:04","slug":"overwater-ventures-closes-20m-debut-fund","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/","title":{"rendered":"Overwater Ventures Closes $20M Debut Fund"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Andreessen Horowitz and Khosla Ventures veteran Kristina Simmons launches firm to support founders commercializing science and technology for human and planet health<\/i><\/p>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.overwater.vc%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Overwater+Ventures&amp;index=1&amp;md5=df4a1164d3cc38247a87ad482f1cf8cc\" rel=\"nofollow noopener\" shape=\"rect\">Overwater Ventures<\/a>, an early-stage venture capital firm, supporting the next generation of founders in human and planet health, today announced the close of its $20 million inaugural fund. Participants in the round include well-known institutional family offices, experienced founders and investors. Founded and led by Kristina Simmons, a former partner at Andreessen Horowitz (a16z) and Chief of Staff and Investor at Khosla Ventures, Overwater Ventures makes strategic investments in early-stage companies pushing the boundaries of biology, healthcare, AI, robotics, climate tech and the future of food.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/5\/Overwater_Horizontal_Full-Color.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/21\/Overwater_Horizontal_Full-Color.jpg\"><\/a><\/p>\n<p>\n\u201cSome of the greatest innovation, with the highest potential for societal and economic impact, is happening in digital health, biotech and climate right now,&#8221; said Simmons, founder and managing partner at Overwater Ventures. \u201cI created Overwater to help founders more easily bridge the gap between a successful technology and a scalable business that people love.\u201d<\/p>\n<p>\nSimmons continued, \u201cBrand building starts with founders; we want to help them stay above water so they can build the best possible version of their company. I&#8217;m grateful that an all-star roster of investors and founders share this vision and are on board for Fund I with our mission to create a firm that entrepreneurs associate with industry-disrupting breakthrough companies.\u201d<\/p>\n<p>\nOverwater\u2019s Fund I has already invested in a number of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Foverwater.vc%2Fportfolio%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=portfolio+companies&amp;index=2&amp;md5=ab22dbaee6231bb1f25d7764ef6c7d2b\" rel=\"nofollow noopener\" shape=\"rect\">portfolio companies<\/a> that reflect its mission. Examples include:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.overstory.com%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Overstory&amp;index=3&amp;md5=752dfbe9d4ab178a9fc4634ad22a81db\" rel=\"nofollow noopener\" shape=\"rect\">Overstory<\/a>, a company that successfully reduced power outages and wildfires as it has analyzed over 500 million hectares of land.<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fweconceive.com%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Conceive&amp;index=4&amp;md5=65409af3f47424630b94f5109abb82b2\" rel=\"nofollow noopener\" shape=\"rect\">Conceive<\/a>, named one of Fast Company&#8217;s Most Innovative Companies, has helped 64% of its users to become pregnant within 6 months.<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gametogen.com%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Gameto&amp;index=5&amp;md5=2dd68b1521c2542b3a1508b4d15ceb27\" rel=\"nofollow noopener\" shape=\"rect\">Gameto<\/a> has licensed technology from Harvard\u2019s Wyss Institute to grow <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Furl2.mailanyone.net%2Fscanner%3Fm%3D1pjRlj-000A9h-4t%26d%3D4%257Cmail%252F90%252F1680557400%252F1pjRlj-000A9h-4t%257Cin2k%257C57e1b682%257C28197542%257C13654142%257C642B45A396E42B06F5B42D173AB9A6BB%26o%3D%252Fphty%253A%252Fwtsahssdrvr.awu.e%252Fnesd%252Flegaco-imtyeens-wsssus-ieittntoes-ohnltcgfgyor-r-omgwinhuan-sa-ofie-vrv-roraramhrnd-ivesui%252Fyt%26s%3DgdJPIjpTxUJf6QSGKbiC2uYWhAQ&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=human+ovaries&amp;index=6&amp;md5=24ce3bb82aee571b04b88855debcb2ef\" rel=\"nofollow noopener\" shape=\"rect\">human ovaries<\/a> and has promising results from pre-clinical studies for its fertility therapy, Fertilo.<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fzeroacre.com%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Zero+Acre+Farms&amp;index=7&amp;md5=6b92619e7e683736dc84b7a501495ab9\" rel=\"nofollow noopener\" shape=\"rect\">Zero Acre Farms<\/a> launched a cooking oil made by fermentation to reduce deforestation and improve human health and recently announced an investment from Chipotle.<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.prosefoods.com%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Prose+Foods&amp;index=8&amp;md5=f8b9fed65d17717270015a8008a5a58f\" rel=\"nofollow noopener\" shape=\"rect\">Prose Foods<\/a> is building a protein discovery platform for healthier and more sustainable foods.<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.overture.life%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Overture+Life&amp;index=9&amp;md5=c802c2fa6565b4352abd70fd86fe1015\" rel=\"nofollow noopener\" shape=\"rect\">Overture Life<\/a> is revolutionizing egg freezing and IVF, and recently achieved the first baby born with its technology.<\/li>\n<\/ul>\n<p>\n\u201cKristina is a passionate investor that draws energy from helping early stage founders. Her broad network helps founders ask and answer key brand questions in the early stages that can make or break a company,\u201d said Vinod Khosla, founder of Khosla Ventures.<\/p>\n<p>\nOverwater takes a holistic approach with its portfolio companies. According to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.consultancy.com.au%2Fnews%2F1412%2Fstartup-founders-closing-their-eyes-to-their-own-health&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=KPMG&amp;index=10&amp;md5=8860cfa8f7091f920179bcc36b9c1d92\" rel=\"nofollow noopener\" shape=\"rect\">KPMG<\/a>, just 20% of founders are satisfied with their mental health and wellness. With the understanding that better humans make better companies, Overwater will offer both business and personal support including programs focused on mental and physical well-being to help founders reach their leadership potential, believing this is key to entrepreneurs\u2019 success and the work they bring to the world.<\/p>\n<p>\nSimmons has deep tenure in venture capital and brand building. At lululemon athleta, she helped launch the brand\u2019s ecommerce, social, and digital platforms, and eventually, co-founded the company\u2019s Emerging Products &amp; Concepts efforts. As a partner at Andreessen Horowitz, she connected portfolio companies to Fortune 500 brands, helping them scale in new ways. As an investment team partner and chief of staff at Khosla Ventures, she invested in early stage companies and served on the boards of startups like Alivecor, Overture Life and Ginger.<\/p>\n<p>\n<b>About Overwater Ventures<\/b><\/p>\n<p>\nOverwater Ventures is an early-stage venture capital firm that helps founders turn breakthrough technologies into focus on making people and the planet into scalable businesses people love. The firm gives founders the support they need to quickly turn their vision into a sustainable, high-growth business with the aim to create both societal and economic outsized returns. Overwater Ventures is committed to partnering with and funding founders working on science and technology that, once commercialized, has the potential to radically impact human lives and the planet. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Foverwater.vc%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=https%3A%2F%2Foverwater.vc%2F&amp;index=11&amp;md5=5037cd3c91faef50b0c18dd409bc3623\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/overwater.vc\/<\/a> or follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Foverwater-ventures%2F&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=12&amp;md5=4dec74d68214540a87ca3712c68dbfd7\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a> or <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FOverwaterVC&amp;esheet=53379890&amp;newsitemid=20230412005270&amp;lan=en-US&amp;anchor=Twitter&amp;index=13&amp;md5=80d24b3d095eb27835c21195b3460a92\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nNatalee Gibson<br \/>\n<br \/>Songue PR<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;&#111;ver&#x77;&#x61;&#x74;&#x65;&#x72;&#64;&#115;&#111;ngu&#x65;&#x70;&#x72;&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6f;&#x76;&#101;&#114;&#119;a&#x74;&#x65;&#x72;&#64;&#115;on&#x67;&#x75;&#x65;&#112;&#114;&#46;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Andreessen Horowitz and Khosla Ventures veteran Kristina Simmons launches firm to support founders commercializing science and technology for human and planet health SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Overwater Ventures, an early-stage venture capital firm, supporting the next generation of founders in human and planet health, today announced the close of its $20 million inaugural fund. Participants in the &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55736","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Overwater Ventures Closes $20M Debut Fund - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Overwater Ventures Closes $20M Debut Fund - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Andreessen Horowitz and Khosla Ventures veteran Kristina Simmons launches firm to support founders commercializing science and technology for human and planet health SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Overwater Ventures, an early-stage venture capital firm, supporting the next generation of founders in human and planet health, today announced the close of its $20 million inaugural fund. Participants in the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T13:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/21\/Overwater_Horizontal_Full-Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Overwater Ventures Closes $20M Debut Fund\",\"datePublished\":\"2023-04-12T13:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/\"},\"wordCount\":679,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005270\\\/en\\\/1761576\\\/21\\\/Overwater_Horizontal_Full-Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/\",\"name\":\"Overwater Ventures Closes $20M Debut Fund - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005270\\\/en\\\/1761576\\\/21\\\/Overwater_Horizontal_Full-Color.jpg\",\"datePublished\":\"2023-04-12T13:03:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005270\\\/en\\\/1761576\\\/21\\\/Overwater_Horizontal_Full-Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005270\\\/en\\\/1761576\\\/21\\\/Overwater_Horizontal_Full-Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overwater-ventures-closes-20m-debut-fund\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Overwater Ventures Closes $20M Debut Fund\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Overwater Ventures Closes $20M Debut Fund - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/","og_locale":"en_US","og_type":"article","og_title":"Overwater Ventures Closes $20M Debut Fund - Pharma Trend","og_description":"Andreessen Horowitz and Khosla Ventures veteran Kristina Simmons launches firm to support founders commercializing science and technology for human and planet health SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Overwater Ventures, an early-stage venture capital firm, supporting the next generation of founders in human and planet health, today announced the close of its $20 million inaugural fund. Participants in the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-12T13:03:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/21\/Overwater_Horizontal_Full-Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Overwater Ventures Closes $20M Debut Fund","datePublished":"2023-04-12T13:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/"},"wordCount":679,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/21\/Overwater_Horizontal_Full-Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/","url":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/","name":"Overwater Ventures Closes $20M Debut Fund - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/21\/Overwater_Horizontal_Full-Color.jpg","datePublished":"2023-04-12T13:03:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/21\/Overwater_Horizontal_Full-Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230412005270\/en\/1761576\/21\/Overwater_Horizontal_Full-Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/overwater-ventures-closes-20m-debut-fund\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Overwater Ventures Closes $20M Debut Fund"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55736"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55736\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}